K
Koichi Nakao
Researcher at Kumamoto University
Publications - 173
Citations - 4391
Koichi Nakao is an academic researcher from Kumamoto University. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 24, co-authored 150 publications receiving 3248 citations.
Papers
More filters
Journal ArticleDOI
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial
Hirotoshi Watanabe,Takenori Domei,Takeshi Morimoto,Masahiro Natsuaki,Hiroki Shiomi,Toshiaki Toyota,Masanobu Ohya,Satoru Suwa,Kensuke Takagi,Mamoru Nanasato,Yoshiki Hata,Masahiro Yagi,Nobuhiro Suematsu,Takafumi Yokomatsu,Itaru Takamisawa,Masayuki Doi,Toshiyuki Noda,Hideki Okayama,Yoshitane Seino,Tomohisa Tada,Hiroki Sakamoto,Kiyoshi Hibi,Mitsuru Abe,Kazuya Kawai,Koichi Nakao,Kenji Ando,Kengo Tanabe,Yuji Ikari,Keiichi Igarashi Hanaoka,Yoshihiro Morino,Ken Kozuma,Kazushige Kadota,Yutaka Furukawa,Yoshihisa Nakagawa,Takeshi Kimura +34 more
TL;DR: It is suggested that a shorter duration of DAPT may provide benefit, although given study limitations, additional research is needed in other populations.
Journal ArticleDOI
Nitric Oxide Activity Is Deficient in Spasm Arteries of Patients With Coronary Spastic Angina
Kiyotaka Kugiyama,Hirofumi Yasue,Ken Okumura,Hisao Ogawa,Kazuteru Fujimoto,Koichi Nakao,Michihiro Yoshimura,Takeshi Motoyama,Yoshito Inobe,Hiroaki Kawano +9 more
TL;DR: There is a deficiency in endothelial NO activity in spasm arteries, which leads to the supersensitivity of the artery to the vasodilator effect of nitroglycerin and to the Vasoconstrictor effect of acetylcholine in patients with CSA, which plays an important role in the pathogenesis of coronary spasm.
Journal ArticleDOI
Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.
Y. Saito,Koichi Nakao,Kazunobu Nishimura,Akira Sugawara,Ken Okumura,Kenji Obata,Ryuji Sonoda,Toshihiko Ban,Hirofumi Yasue,Hiroo Imura +9 more
TL;DR: The findings indicate that the ANP infusion improves left ventricular function in patients with CHF, and suggest that this improvement results mainly from the vasodilating activity of ANP.
Journal ArticleDOI
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.
Kazuo Kimura,Takeshi Kimura,Masaharu Ishihara,Yoshihisa Nakagawa,Koichi Nakao,Katsumi Miyauchi,Tomohiro Sakamoto,Kenichi Tsujita,Nobuhisa Hagiwara,Shunichi Miyazaki,Junya Ako,Hirokuni Arai,Hideki Ishii,Hideki Origuchi,Wataru Shimizu,Hirofumi Takemura,Yoshio Tahara,Yoshihiro Morino,Kenji Iino,Tomonori Itoh,Yoshitaka Iwanaga,Keiji Uchida,Hirohisa Endo,Ken Kongoji,Kenji Sakamoto,Hiroki Shiomi,Takao Shimohama,Atsushi Suzuki,Jun Takahashi,Ichiro Takeuchi,Akihito Tanaka,Toshihiro Tamura,Takahiro Nakashima,Teruo Noguchi,Daisuke Fukamachi,Tomohiro Mizuno,Junichi Yamaguchi,Kenji Yodogawa,Masami Kosuge,Shun Kohsaka,Hideaki Yoshino,Satoshi Yasuda,Hiroaki Shimokawa,Atsushi Hirayama,Takashi Akasaka,Kazuo Haze,Hisao Ogawa,Hiroyuki Tsutsui,Tsutomu Yamazaki +48 more
TL;DR: This document is an English version of JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome reported at the Japanese Circulation Society Joint Working Groups performed in 2018.
Journal ArticleDOI
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Kenichi Tsujita,Seigo Sugiyama,Hitoshi Sumida,Hideki Shimomura,Takuro Yamashita,Kenshi Yamanaga,Naohiro Komura,Kenji Sakamoto,Hideki Oka,Koichi Nakao,Sunao Nakamura,Masaharu Ishihara,Kunihiko Matsui,Naritsugu Sakaino,Natsuki Nakamura,Nobuyasu Yamamoto,Shunichi Koide,Toshiyuki Matsumura,Kazuteru Fujimoto,Ryusuke Tsunoda,Yasuhiro Morikami,Koushi Matsuyama,Shuichi Oshima,Koichi Kaikita,Seiji Hokimoto,Hisao Ogawa,Precise–Ivus Investigators +26 more
TL;DR: Compared with standard statin monotherapy, the combination of statin plus ezetimibe showed greater coronary plaque regression, which might be attributed to cholesterol absorption inhibition-induced aggressive lipid lowering.